GW Pharmaceuticals plc
0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS
Case Summary | |
Company Name: | GW Pharmaceuticals plc |
Stock Symbol : | NASDAQ: GWPH |
Class Period Start: | 12/04/2014 |
Class Period End: | 01/08/2016 |
Lead Plaintiff motion: | 03/21/2016 |
Date Filed: | 01/21/2016 |
Type of Case: | Securities Class Action |
Court: | U.S. District Court for the Southern District of New York |
Summary: | Thieler Law Corp advises investors with losses exceeding $100,000 of the March 21, 2016 lead plaintiff deadline in a class action lawsuit filed against GW Pharmaceuticals plc (NASDAQ: GWPH) (“GW Pharmaceuticals ” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of New York and investors, who purchased GW Pharmaceuticals securities between December 4, 2014 and January 8, 2016, have until March 21, 2016 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class. If you purchased GW Pharmaceuticals securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class. The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that GW Pharmaceuticals lacked effective internal financial controls and lacked effective controls over completeness and valuation of clinical trial accruals. As a result, GW Pharmaceuticals statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times. On January 10, 2016, it was reported that GW Pharmaceuticals disclosed material weakness in its internal control over financial reporting for the year ended September 30, 2015 and that the management lacked effective controls over the completeness and assessment of clinical trial accruals. On this news, NASDAQ: GWPH has fallen as much 6% on January 11, 2016. If you were negatively impacted by your investment in GW Pharmaceuticals securities between December 4, 2014 and January 8, 2016 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation. Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Thieler Law Corp 2534 State Street - Suite 406, San Diego, CA 92101 by email: mail@thielerlaw.com or telephone at +1 (619) 377 - 4324 or visit our website http://www.thielerlaw.com/ or Facsimile: +1 (619) 785 – 3185
|